Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.

Παρόμοια τεκμήρια

• Bosentan attenuates the profibrotic gene expression profile of lung fibroblasts in scleroderma
  ανά: Shiwen, X, κ.ά.
  Έκδοση: (2006)
• Effects of bosentan on collagen type I synthesis on in vitro culture of scleroderma skin fibroblasts
  ανά: S. Soldano, κ.ά.
  Έκδοση: (2011-01-01)
• Successful Treatment with Bosentan of Lower Extremity Ulcers in a Scleroderma Patient
  ανά: Alix Naert, κ.ά.
  Έκδοση: (2013-01-01)
• CTGF overexpressing mice: a model for human scleroderma
  ανά: Sonnylal, S, κ.ά.
  Έκδοση: (2006)
• Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients
  ανά: Emma Di Poi, κ.ά.
  Έκδοση: (2023-11-01)